Spectrophotometry for Xanthochromia
to the editor: Xanthochromia, or a yellow appearance of the cerebrospinal fluid, is often used to confirm suspected subarachnoid hemorrhage. 1,2 It is associated with the presence of bilirubin, a blood product that arises only in vivo by the enzymatic transformation of hemoglobin. However, visual assessment of the cerebrospinal fluid for xanthochromia is highly subjective and unreliable, especially in cases in which other blood products, such as oxyhemoglobin, are present. 1,2 The differential diagnosis may be further complicated by a high protein level and a high cell count, as in meningitis and necrosis, or by the presence of other pigments (namely, carotenoids). To distinguish pigments in the cerebrospinal fluid, such as bilirubin, that are clinically important for diagnosing subarachnoid hemorrhage and other types of intracerebral bleeding from those that are not important, objective spectrophotometry, rather than visual assessment, is recommended. Because bilirubin has a characteristic signature -absorbance in the blue range (450 to 460 nm) -it can be readily identified by spectrophotometry. Moreover, by standard colorimetric procedures, which have been established by the Commission Internationale de l'Eclairage (CIE, or the International Commission on Illumination), the A section of the Commission Internationale de l'Eclairage (CIE) 1931 chromaticity diagram is shown, with the x-y chromaticity coordinates of 72 samples of cerebrospinal fluid containing bilirubin (yellow dots) with respect to CIE illuminant D65 (white cross). For reference, the x-y chromaticity coordinates and the wavelengths of the spectral colors from 550 nm (corresponding to greenish yellow) to 620 nm (corresponding to red) are indicated. The region corresponding to pure yellow, which ranges between 575 and 580 nm (as noted by Petzold and Sharpe 4 ), is shown in gray. The pie chart indicates the proportions of samples visually identified as greenish, yellow (xanthochromic), and reddish by trained clinical observers. The full chromaticity diagram is shown in the lower left-hand corner. (Fig. 1) . Spectrophotometric analysis of 632 samples of cerebrospinal fluid, obtained at the National Hospital for Neurology and Neurosurgery in London between January 1996 and April 2004, indicated that 72 contained bilirubin. Of these, only 15 (21 percent) contained bilirubin alone and appeared pure yellow (14 percent) or greenish yellow (7 percent) (Fig. 1) . A significantly higher number, 57 (79 percent; chi-square=49.0, P<0.001), contained oxyhemoglobin as well as bilirubin. Their appearance ranged from red and reddish pink to orange. These findings reveal that about 80 percent of cerebrospinal fluid samples containing substantial amounts of bilirubin are not typically perceived as xanthochromic (i.e., yellow). Equally important, the presence of bilirubin cannot reliably be ruled out in the case of cerebrospinal fluid samples that are visibly red.
In the United Kingdom, the rate of visual assessment of the cerebrospinal fluid fell from 24 percent to 6 percent, whereas the use of spectrophotometry rose from 76 percent to 94 percent, after the introduction of new guidelines for the detection of cerebrospinal fluid pigments. This shift has reduced the estimated error rate from 40 percent to 9 percent. 5
Clearly, xanthochromia on the basis of mere visual assessment is an ambiguous concept clinically, physiologically, and biochemically. Two recent surveys, however, have shown that visual assessment of cerebrospinal fluid samples for xanthochromia is still the most common method used in the United States. 2, 6 We believe that this practice should immediately be reevaluated.
